| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2159731 | Radiotherapy and Oncology | 2009 | 4 Pages |
Abstract
Twelve patients with locally advanced esophageal squamous cell carcinoma were enrolled to evaluate the safety and efficacy of concurrent chemo-radiotherapy. Dose-limiting toxicity was mainly observed at Capecitabine 1500 mg. The maximum-tolerated dose/recommended dose of Capecitabine was 1000 mg. The Kaplan–Meier estimated overall l-year survival rate was 100%.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Bao-sheng Li, Tao Zhou, Zhong-tang Wang, Hong-sheng Li, Hong-fu Sun, Zhi-cheng Zhang, Hai-qun Lin, Yu-mei Wei, He-yi Gong, Wei Huang, Yan Yi, Li-ying Wang,